Commend Fining of Drug Firm for Blocking Rival Companies

European Commission

Target: European Commission

Goal: Thank European Commission for its decision to fine companies that attempt to pay off competitors to control the market.

In order to block competition for product purchases, many companies use unethical means to ensure their success. This was the case with Danish firm Lundbeck, which was fined recently by the European Commission for blocking the supply of cheaper generic-brand anti-depressants. Lundbeck was found to have offered its competitors a pay off in exchange for delaying the release of their cheaper product on the market.

Specifically in the case of anti-depressants, many people’s lives depend on the accessibility of proper medication. Blocking the market to make cheaper products unavailable is not only unethical from a business standpoint, but from a human one as well. It’s no longer about business, it’s about ensuring people’s mental and physical health.

Lundbeck was fined 146 million Euros, about 195 million dollars, for blocking cheaper competitor anti-depressants from being on the market. Lundbeck has said that it disagrees with the fine and plans to appeal the decision. Joaquin Almunia of the European Commission said, “It is unacceptable that a company pays off its competitors to stay out of its market and delay the entry of cheaper medicines. We are confirming that the so-called ‘pay-for-delay’ deals constitute severe infringements.”

Commend the European Commission for its decision not to let companies get away with dictating the market at the expense of consumers’ health.


Dear European Commission,

Thank you for your recent decision to fine the company Lundbeck for attempting to pay off competitor companies. Lundbeck’s pay off of competitors was yet another instance of a company trying to maximize profit at the expense of their consumers and was unacceptable.

This is especially important as the product in question was an anti-depressant medication. The implications for people who may have been unable to afford Lundbeck’s product over a generic product could have been detrimental. Consumers’ mental and physical health may have suffered a direct and dire consequence as a result of Lundbeck’s attempt to control the market and maximize profit. By preventing companies such as Lundbeck from dictating the market, you are taking a crucial stand in promoting consumers’ rights over that of large companies. This decision makes a statement that companies will not be able to have control over consumers’ lives and health at their own benefit.

This sets an important precedent that competitors cannot be bribed into staying out of the market or delaying the release of their product. By fining Lundbeck, you are sending an important message that companies will not be able to get away with harmful actions like this.

Once again, thank you for your decision to hold Lundbeck accountable.


[Your Name Here]

Photo Credit: Wikimedia Commons

Sign the Petition

  • Only your name will be displayed. By signing, you accept our terms and may receive updates on this and related causes.
FacebookCare2 NewsTwitterEmailShare

Leave a Reply

Your email address will not be published. Required fields are marked *


Facebook Comments


52 Signatures

  • Hermann Kastner
  • James Thrailkill
  • Mal Gaff
  • Terrie Phenicie
  • Nancy Petersen
  • Holly Hall
  • Frédérique Pommarat
  • Marianne Oelman
  • Melanie waleski
  • Patricia Reda
1 of 5123...5
Skip to toolbar